ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Brain Diseases
Neurodegenerative Diseases
Nervous System Diseases

Alzheimer's Disease trials near Salt Lake City, UT, USA:

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's...

Active, not recruiting
Alzheimer Disease 6
Dementia of Alzheimer Type
Device: Spectris™ AD - Active
Device: Spectris™ AD - Sham
Cognito Therapeutics
Cognito Therapeutics

Salt Lake City, Utah, United States of America and 69 other locations

and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: ONO-2020

Phase 2

Ono Pharmaceuticals
Ono Pharmaceuticals

Salt Lake City, Utah, United States and 95 other locations

Approximately 90 patients, aged 50 to 80 years, with a diagnosis of early Alzheimer's disease will take part in this research study...

Enrolling
Alzheimer's Disease
Drug: Placebo
Drug: Hydroxypropyl Beta Cyclodextrin

Phase 2

Cyclo Therapeutics

Salt Lake City, Utah, United States of America and 4 other locations

capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...

Enrolling
Alzheimer Disease
Agitation
Drug: KarX-EC
Drug: KarXT

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Bountiful, Utah, United States of America and 254 other locations

This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...

Invitation-only
Alzheimer Disease
Dementia of Alzheimer Type
Device: Sensory Stimulation System (GS120) - Active
Cognito Therapeutics
Cognito Therapeutics

Salt Lake City, Utah, United States of America and 53 other locations

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Phase 3

AriBio

Salt Lake City, Utah, United States of America and 200 other locations

to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's...

Enrolling
Alzheimer Disease
Agitation
Drug: Placebo
Drug: BMS-986368

Phase 2

Celgene
Celgene

Provo, Utah, United States and 54 other locations

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...

Enrolling
Alzheimer Disease
Drug: Xanomeline Enteric Capsule
Drug: Xanomeline/Trospium Chloride Capsule

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Salt Lake City, Utah, United States of America and 152 other locations

Locations recently updated

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Xanomeline Enteric Capsule

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Bountiful, Utah, United States of America and 146 other locations

This is a phase 2 study to evaluate the safety and preliminary evidence of effectiveness of azeliragon, in combination with radiation therapy, as an...

Active, not recruiting
Glioblastoma
Drug: Azeliragon

Phase 2

Cantex Pharmaceuticals

Salt Lake City, Utah, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems